The quality management system of the biotechnology company R-Biopharm complies with the European In Vitro Diagnostic Regulation (IVDR).
Quality orientation is an integral part of the culture and processes at R-Biopharm. The biotechnology company from southern Hesse thus ensures that quality is integrated throughout the entire company and continually improved in order to deliver reliable products for the health of patients in the long term.
The family owned company has regular audits conducted to check the suitability and functionality of all quality-related elements. In the autumn of 2021, R-Biopharm was one of the first companies to undergo the comprehensive audit for the new IVDR certification by TÜV SÜD and has now received the certificate.
With its holistic quality management system, R-Biopharm ensures that normative and regulatory requirements are fulfilled from the development to the application of products and that correspondingly high-quality standards apply. "In our company, quality is not the action of a few but rather the attitude of all our employees", says board member Dr Hans Frickel. "Our focus on quality is also highly relevant internally. By applying quality-oriented standards, we can detect risks and errors, efficiently design working methods, identify our strengths and potentials, and derive needs for action that will help us to continually improve."